Skip to main content

Advertisement

SpringerLink
Log in

Postpartum Hypertension and the Role of Postpartum Clinics and Digital Health

  • Reproductive Health and Cardiovascular Disease (G Sharma, Section Editor)
  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Abstract

Purpose of review

Postpartum hypertension is common, vastly underrecognized and increases the risk for future cardiovascular events. One of the most common risk factors for the development of postpartum hypertension is preexistent hypertensive disorders of pregnancy (HDP). According to Cirillo and Cohn (2015), HDP complicate 5–10% of pregnancies worldwide, and their prevalence is increasing. Unfortunately, many clinicians and patients are not aware of the risks associated with HDP, nor are they aware of the importance of monitoring blood pressure in the postpartum period. Telemedicine and digital health may improve the detection and treatment of postpartum hypertension.

Recent findings

During the first year after delivery, women with HDP have a 12- to 25-fold greater risk of developing chronic hypertension (HTN), which is the most common cause for readmission. In addition to HDP, there are also secondary causes of HTN that need to be considered in the appropriate setting such as medications and endocrine and renal disorders. There is little data regarding the effectiveness of antihypertensive medications and the role of diet and exercise in the management of postpartum HTN. Early postpartum healthcare follow-up is associated with better maternal and fetal outcomes, as discussed by Goulet et al. (2007). Yet, McKinney et al. (2018) estimated that only 40% of women attend face-to-face follow-up with a healthcare provider 6 weeks after delivery. This emphasizes the need for innovative models to improve rates of follow-up and better accessibility of healthcare monitoring and intervention for postpartum women.

Summary

Screening for postpartum HTN is essential. The establishment of structured follow-up incorporating postpartum clinics, whether remote or in-person, would allow monitoring of blood pressure, increasing the detection and treatment of postpartum HTN and improving its management and treatment. These visits also provide an opportunity for providers to assess and educate women about other modifiable cardiovascular risk factors with the goal of reducing their overall cardiovascular risk profile and likelihood of future cardiac events. Digital health resources and interventions are becoming readily available and more popular among mothers when compared to in-person follow-up. This is likely due to lower burden of transportation, less cost, and availability of online support. Finally, further clinical studies investigating antihypertensive medications and the effect of diet and exercise on postpartum hypertension are critical.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the child health and development studies pregnancy cohort. Circulation. 2015;132(13):1234–42. https://doi.org/10.1161/CIRCULATIONAHA.113.003901.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67(8):1–50.

    PubMed  Google Scholar 

  3. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21(5):521–6. https://doi.org/10.1038/ajh.2008.20.

    Article  PubMed  Google Scholar 

  4. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974. https://doi.org/10.1136/bmj.39335.385301.BE.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tooher J, Thornton C, Makris A, Ogle R, Korda A, Hennessy A. All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease. Hypertension. 2017;70(4):798–803. https://doi.org/10.1161/HYPERTENSIONAHA.117.09246 Tooher et al. performed a retrospective analysis of 31,656 women evaluating risk factors for severe hypertension. Close to 14% had HDP and 34% of this cohort had severe HTN defined as BP ≥170/110mmHg. The women with severe HTN tended to be older, delivered earlier, and had lower neonatal weights when compared to women who were normotensive during pregnancy.

  6. Gestational hypertension and preeclampsia: ACOG practice bulletin summary, number 222. Obstet Gynecol. 2020;135(6):1492–5. https://doi.org/10.1097/AOG.0000000000003892.

  7. Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation. 2015;132(18):1726–33. https://doi.org/10.1161/CIRCULATIONAHA.115.015721.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118(5):1102–7. https://doi.org/10.1097/AOG.0b013e318231934c.

    Article  PubMed  Google Scholar 

  9. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–324. https://doi.org/10.1161/HYP.0000000000000066.

    Article  CAS  PubMed  Google Scholar 

  10. Sutton ALM, Harper LM, Tita ATN. Hypertensive disorders in pregnancy. Obstet Gynecol Clin N Am. 2018;45(2):333–47. https://doi.org/10.1016/j.ogc.2018.01.012.

    Article  Google Scholar 

  11. Sutton EF, Hauspurg A, Caritis SN, Powers RW, Catov JM. Maternal outcomes associated with lower range stage 1 hypertension. Obstet Gynecol. 2018;132(4):843–9. https://doi.org/10.1097/AOG.0000000000002870.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Smith GN, Pudwell J, Saade GR. Impact of the new American hypertension guidelines on the prevalence of postpartum hypertension. Am J Perinatol. 2019;36(4):440–2. https://doi.org/10.1055/s-0038-1669441.

    Article  PubMed  Google Scholar 

  13. Sisti G, Williams B. Body of evidence in favor of adopting 130/80 mm Hg as new blood pressure cut-off for all the hypertensive disorders of pregnancy. Medicina (Kaunas). 2019;55(10). https://doi.org/10.3390/medicina55100703.

  14. Hauspurg A, Parry S, Mercer BM, Grobman W, Hatfield T, Silver RM, et al. Blood pressure trajectory and category and risk of hypertensive disorders of pregnancy in nulliparous women. Am J Obstet Gynecol. 2019;221(3):277 e1- e8. https://doi.org/10.1016/j.ajog.2019.06.031.

    Article  Google Scholar 

  15. Melchiorre K, Thilaganathan B, Giorgione V, Ridder A, Memmo A, Khalil A. Hypertensive disorders of pregnancy and future cardiovascular health. Front Cardiovasc Med. 2020;7:59. https://doi.org/10.3389/fcvm.2020.00059.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Hauspurg A, Lemon L, Cabrera C, Javaid A, Binstock A, Quinn B, et al. Racial differences in postpartum blood pressure trajectories among women after a hypertensive disorder of pregnancy. JAMA Netw Open. 2020;3(12):e2030815. https://doi.org/10.1001/jamanetworkopen.2020.30815.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2012;206(6):470–5. https://doi.org/10.1016/j.ajog.2011.09.002.

    Article  PubMed  Google Scholar 

  18. Benschop L, Duvekot JJ, Versmissen J, van Broekhoven V, Steegers EAP. Roeters van Lennep JE. Blood pressure profile 1 year after severe preeclampsia. Hypertension. 2018;71(3):491–8. https://doi.org/10.1161/HYPERTENSIONAHA.117.10338.

    Article  CAS  PubMed  Google Scholar 

  19. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy. 2002;21(1):85–95. https://doi.org/10.1081/PRG-120002912.

    Article  CAS  PubMed  Google Scholar 

  20. Cairns AE, Pealing L, Duffy JMN, Roberts N, Tucker KL, Leeson P, et al. Postpartum management of hypertensive disorders of pregnancy: a systematic review. BMJ Open. 2017;7(11):e018696. https://doi.org/10.1136/bmjopen-2017-018696.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Drugs and lactation database (LactMed) [Internet] [database on the Internet]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/. Accessed:

  22. Katzung BG, Trevor AJ. Basic & clinical pharmacology. 13th ed: McGraw Hill Education; 2015.

  23. Noronha Neto CC, Maia SS, Katz L, Coutinho IC, Souza AR, Amorim MM. Clonidine versus captopril for severe postpartum hypertension: a randomized controlled trial. PLoS One. 2017;12(1):e0168124. https://doi.org/10.1371/journal.pone.0168124.

    Article  CAS  Google Scholar 

  24. Ascarelli MH, Johnson V, McCreary H, Cushman J, May WL, Martin JN Jr. Postpartum preeclampsia management with furosemide: a randomized clinical trial. Obstet Gynecol. 2005;105(1):29–33. https://doi.org/10.1097/01.AOG.0000148270.53433.66.

    Article  CAS  PubMed  Google Scholar 

  25. Lopes Perdigao J, Lewey J, Hirshberg A, Koelper N, Srinivas SK, Elovitz MA, et al. Furosemide for accelerated recovery of blood pressure postpartum in women with a hypertensive disorder of pregnancy: a randomized controlled trial. Hypertension. 2021:HYPERTENSIONAHA12016133. https://doi.org/10.1161/HYPERTENSIONAHA.120.16133.

  26. Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev. 2015;6:CD007145. https://doi.org/10.1002/14651858.CD007145.pub3.

    Article  Google Scholar 

  27. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336(16):1117–24. https://doi.org/10.1056/NEJM199704173361601.

    Article  CAS  PubMed  Google Scholar 

  28. Gibbs J, Gaskin E, Ji C, Miller MA, Cappuccio FP. The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials. J Hypertens. 2021;39(1):23–37. https://doi.org/10.1097/HJH.0000000000002604.

    Article  CAS  PubMed  Google Scholar 

  29. McKinney J, Keyser L, Clinton S, Pagliano C. ACOG Committee opinion no. 736: optimizing postpartum care. Obstet Gynecol. 2018;132(3):784–5. https://doi.org/10.1097/AOG.0000000000002849 The American College of Obstetricians and Gynecologists discuss postpartum evaluation algorithm which assigns responsibility to the maternal primary care provider for comprehensive postpartum care.

  30. Patient S. Quality committee SfM-FMEasso, Gibson KS, Hameed AB. Society for maternal-fetal medicine special statement: checklist for postpartum discharge of women with hypertensive disorders. Am J Obstet Gynecol. 2020;223(4):B18–21. https://doi.org/10.1016/j.ajog.2020.07.009.

    Article  Google Scholar 

  31. Haug EB, Horn J, Markovitz AR, Fraser A, Klykken B, Dalen H, et al. Association of conventional cardiovascular risk factors with cardiovascular disease after hypertensive disorders of pregnancy: analysis of the Nord-Trondelag health study. JAMA Cardiol. 2019;4(7):628–35. https://doi.org/10.1001/jamacardio.2019.1746.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bello NA, Miller E, Cleary K, Wapner R, Shimbo D, Tita AT. Out of office blood pressure measurement in pregnancy and the postpartum period. Curr Hypertens Rep. 2018;20(12):101. https://doi.org/10.1007/s11906-018-0901-z.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Goulet L, D'Amour D, Pineault R. Type and timing of services following postnatal discharge: do they make a difference? Women Health. 2007;45(4):19–39. https://doi.org/10.1300/J013v45n04_02.

    Article  PubMed  Google Scholar 

  34. Spartano NL, Lin H, Sun F, Lunetta KL, Trinquart L, Valentino M, et al. Comparison of on-site versus remote Mobile device support in the Framingham heart study using the health eHeart study for digital follow-up: randomized pilot study set within an observational study design. JMIR Mhealth Uhealth. 2019;7(9):e13238. https://doi.org/10.2196/13238.

    Article  PubMed  PubMed Central  Google Scholar 

  35. van den Heuvel JFM, Lely AT, Huisman JJ, JCA T, Franx A, Bekker MN. SAFE@HOME: digital health platform facilitating a new care path for women at increased risk of preeclampsia - a case-control study. Pregnancy Hypertens. 2020;22:30–6. https://doi.org/10.1016/j.preghy.2020.07.006 The importance of digital platforms in the care of women during pregnancy. The authors designed a digital platform for daily blood pressure and symptom monitoring starting from 16 weeks of gestation and compared to a retrospective control group managed without self-monitoring. Women enrolled in the digital platform had lower antenatal visits, yet fewer admissions for hypertension or suspected preeclampsia.

  36. Hoppe KK, Williams M, Thomas N, Zella JB, Drewry A, Kim K, et al. Telehealth with remote blood pressure monitoring for postpartum hypertension: a prospective single-cohort feasibility study. Pregnancy Hypertens. 2019;15:171–6. https://doi.org/10.1016/j.preghy.2018.12.007.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, S3-860, Worcester, MA, USA

    Colleen M. Harrington, Nouran Sorour, Marissa Ciuffo, Nicole Sardella, Gerard P. Aurigemma & Lara C. Kovell

  2. Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA

    Stephen Troy

  3. University of Massachusetts Medical School, Worcester, MA, USA

    Mina Botros

  4. Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Massachusetts Medical School, Worcester, MA, USA

    Gianna Wilkie

Authors
  1. Colleen M. Harrington
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nouran Sorour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen Troy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mina Botros
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marissa Ciuffo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicole Sardella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gianna Wilkie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gerard P. Aurigemma
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lara C. Kovell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Colleen M. Harrington.

Ethics declarations

Conflict of interest

Colleen M. Harrington declares that she has no conflict of interest.

Nouran Sorour declares that she has no conflict of interest.

Stephen Troy declares that he has no conflict of interest.

Mina Botros declares that he has no conflict of interest.

Marissa Ciuffo declares that she has no conflict of interest.

Nicole Sardella declares that she has no conflict of interest.

Gianna Wilkie declares that she has no conflict of interest.

Gerard P. Aurigemma declares that he has no conflict of interest.

Lara C. Kovell declares that she has no conflict of interest.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Reproductive Health and Cardiovascular Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harrington, C.M., Sorour, N., Troy, S. et al. Postpartum Hypertension and the Role of Postpartum Clinics and Digital Health. Curr Treat Options Cardio Med 23, 59 (2021). https://doi.org/10.1007/s11936-021-00937-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11936-021-00937-y

Keywords

Search

Navigation